Integrative Approaches for Cancer Survivorship 2: Project 2
Status: | Completed |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/7/2019 |
Start Date: | September 2016 |
End Date: | June 4, 2018 |
Developing a Health Education Intervention for Breast Cancer Survivorship
The purpose of this study is to develop and test a 6 month manualized Health Education
intervention in recent breast cancer survivors.
intervention in recent breast cancer survivors.
Post-treatment cancer survivorship is often associated with a void in care given the drop-off
in support provided to survivors from the medical team as well as family and friends. The
investigators aim to develop and test a Health Education intervention in breast cancer
survivors. Specifically, the investigators aim to develop the manualized Health Education
intervention; to assess feasibility; and to provide preliminary data on the effects of the
intervention. The data from this pilot study will be used to inform future study.
in support provided to survivors from the medical team as well as family and friends. The
investigators aim to develop and test a Health Education intervention in breast cancer
survivors. Specifically, the investigators aim to develop the manualized Health Education
intervention; to assess feasibility; and to provide preliminary data on the effects of the
intervention. The data from this pilot study will be used to inform future study.
Inclusion Criteria:
- Female breast cancer survivor who is over 1 month and less than 24 months beyond the
completion of primary therapy (surgery, radiation, and chemotherapy)
- Having received chemotherapy as part of their primary therapy for breast cancer
- Be in complete remission
- Aged 18 years or older
- Able to read, write, and understand English
- Karnofsky Performance Status (KPS) greater than or equal to 60
- Have impaired quality of life
- Ability to give informed consent
Exclusion Criteria:
- Receiving chemotherapy or radiotherapy at the time of study enrollment. Anti-her2
directed therapy is not exclusionary.
- Being within 1 month (before or after) of surgery for breast cancer (including breast
reconstructive surgery). Smaller surgical procedures such as implant exchange are not
exclusionary.
- Patients on adjuvant hormone therapy for less than 2 months
- Have surgery for breast cancer or breast reconstructive surgery planned during the
initial 6 month study period. Smaller surgical procedures such as implant exchange are
not exclusionary.
We found this trial at
1
site
San Francisco, California 94115
Click here to add this to my saved trials